Carina Masferrer Ferragutcasas I am a phD student in the Biochemistry, Molecular Biology and Biomedicine program from the Universitat Autònoma de Barcelona. Since 2020 I have been developing my thesis in the Biomedical Research in Gynaecology group at the Vall d'Hebron Institute of Research (VHIR) under the supervision of Dr. Eva Colás. My research aims, on the one hand, to analyse, understand, and work on the molecular profile of patients with endometriosis. On the other hand, it is focused in exploring and improving new treatment strategies for endometrial cancer patients. Institutions of which they are part Research technician Biomedical Research in Gynaecology Vall Hebron Institut de Recerca LinkedIn Twitter Email Carina Masferrer Ferragutcasas LinkedIn Twitter Email Institutions of which they are part Research technician Biomedical Research in Gynaecology Vall Hebron Institut de Recerca I am a phD student in the Biochemistry, Molecular Biology and Biomedicine program from the Universitat Autònoma de Barcelona. Since 2020 I have been developing my thesis in the Biomedical Research in Gynaecology group at the Vall d'Hebron Institute of Research (VHIR) under the supervision of Dr. Eva Colás. My research aims, on the one hand, to analyse, understand, and work on the molecular profile of patients with endometriosis. On the other hand, it is focused in exploring and improving new treatment strategies for endometrial cancer patients.
After studying my bachelor's degree in Biomedical Sciences at Universitat de Barcelona, I pursued the master's programme in Translational Biomedical Research at the Vall d'Hebron Institute of Research (VHIR), aiming to direct my professional career to the clinical field. Due to my interest in gynaecology, I carried out its curricular internship in the Biomedical Research in Gynaecology group, developing the project “Study of Phototrexate as a possible therapeutic agent for endometrial cancer”. The sponsorship of the "Mocador Solidari" initiative, promoted by Vall d'Hebron with the collaboration of Natura and Judit Mascó as its ambassador, allowed me to join the group as a phD student under the supervision of Dr. Eva Colás. Within this project I am currently working to develop new therapeutic strategies for improving the treatment of endometrial cancer. This cancer is the most common gynaecologic malignancy, accounting for 6% of diagnosed cancers in women. More specifically, we are studying the efficacy of the combination of immunotherapy with the ABTL0812 molecule, which has previously demonstrated good results in this type of cancer. This could specially improve the therapeutic options of patients with aggressive subtypes of endometrial cancer. Simultaneously, I also collaborate with the clinical team of the hospital's Gynaecology Service to analyse, understand, and work on the molecular profile of patients with endometriosis. We aim to progress and individualize their clinical management, regarding both the diagnostic process and therapeutic options, to improve the quality of life of those patients.
Projects A dual liquid biopsy strategy in endometrial cancer: evaluation of risk of recurrence and pesonalized therapy. IP: Antonio Gil Moreno Collaborators: Vicente Bebia Conesa, Angel García Jiménez, Carina Masferrer Ferragutcasas, Montserrat Cubo Abert, A dual liquid biopsy strategy in endometrial cancer: evaluation of risk of recurrence and pesonalized therapy., Marta Rebull Santamaria, Melek Denizli Funding agency: Instituto de Salud Carlos III Funding: 209330 Reference: PI20/01566 Duration: 01/01/2021 - 31/12/2023 ADVANCING ON THE DEVELOPMENT OF A NON-INVASIVE TOOL TO EARLY DIAGNOSE ENDOMETRIAL CANCER IP: Eva Colas Ortega Collaborators: Carina Masferrer Ferragutcasas, Fco Javier De la Torre Fdez de Vega, Silvia Cabrera Diaz, Irene De la Calle Fuentes, Beatriz Villafranca Magdalena Funding agency: Instituto de Salud Carlos III Funding: 135520 Reference: PI20/00644 Duration: 01/01/2021 - 31/12/2024 Targeting the most aggressive type of endometrial carcinoma IP: Antonio Gil Moreno Collaborators: Carina Masferrer Ferragutcasas, Marta Rebull Santamaria, Irene De la Calle Fuentes, Beatriz Villafranca Magdalena, Melek Denizli, Melissa Bradbury Lobato, Raquel Delgado Gil Funding agency: Asociación Española Contra el Cáncer Funding: 199250 Reference: GCTRA18014MATI Duration: 18/02/2019 - 31/10/2024 Pagination First page « Previous page ‹ Page 1 Current page 2
